NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Actelion Ltd (ETR: ACT)
ACT Technical Analysis
4
As on 27th Oct 2017 ACT Share Price closed @ 240.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 215.43 & Buy for SHORT-TERM with Stoploss of 238.67 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ACT Share Price
Open | 239.00 | Change | Price | % |
High | 240.05 | 1 Day | 0.00 | 0.00 |
Low | 239.00 | 1 Week | 0.00 | 0.00 |
Close | 240.00 | 1 Month | 5.50 | 2.35 |
Volume | 114 | 1 Year | 110.10 | 84.76 |
52 Week High 266.90 | 52 Week Low 134.65 |
ETR Germany Most Active Stocks
DTE | 15.31 | -2.11% |
DBK | 14.13 | 1.29% |
EOAN | 10.38 | 2.47% |
CBK | 11.88 | 0.93% |
IFX | 24.51 | 4.30% |
LHA | 28.21 | 2.96% |
DAI | 73.07 | 2.50% |
BIR | 0.24 | 0.00% |
TKA | 23.49 | 2.53% |
MEO | 29.18 | 0.00% |
ETR Germany Top Gainers Stocks
ETR Germany Top Losers Stocks
ACT Daily Charts |
ACT Intraday Charts |
Whats New @ Bazaartrend |
ACT Free Analysis |
|
ACT Important Levels Intraday
SUPPORT | 0.00 |
SUPPORT | 0.00 |
RESISTANCE | 240.97 |
RESISTANCE | 240.57 |
SUPPORT | 239.43 |
SUPPORT | 239.03 |
SUPPORT | 0.00 |
SUPPORT | 0.00 |
ACT Target for Month January
4th UP TARGET | 250.69 |
3rd UP TARGET | 247.26 |
2nd UP TARGET | 245.14 |
1st UP TARGET | 243.02 |
1st DOWN TARGET | 236.98 |
2nd DOWN TARGET | 234.86 |
3rd DOWN TARGET | 232.74 |
4th DOWN TARGET | 229.31 |
ACT Weekly Target
4th UP TARGET | 0.00 |
3rd UP TARGET | 0.00 |
2nd UP TARGET | 0.00 |
1st UP TARGET | 0.00 |
1st DOWN TARGET | 0.00 |
2nd DOWN TARGET | 0.00 |
3rd DOWN TARGET | 0.00 |
4th DOWN TARGET | 0.00 |
ACT Target for Year 2021
4th UP TARGET | 0 |
3rd UP TARGET | 0 |
2nd UP TARGET | 0 |
1st UP TARGET | 0 |
1st DOWN TARGET | 0 |
2nd DOWN TARGET | 0 |
3rd DOWN TARGET | 0 |
4th DOWN TARGET | 0 |
Actelion Ltd ( ETR Germany Symbol : ACT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ACT Other Details
Segment | EQ | |
Market Capital | 0.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
ACT Address
![]() |
Gewerberstrasse 16 Allschwil, 4123 Switzerland Phone: 41 61 565 65 65 Fax: 41 61 565 65 00 |
ACT Latest News
ACT Business Profile
Actelion Ltd, a biopharmaceutical company, discovers, develops, and commercializes drugs for diseases with unmet medical needs. Its products include Tracleer, a dual endothelin receptor antagonist for the treatment of pulmonary arterial hypertension (PAH), a chronic and life-threatening disorder that severely compromises the functions of the lungs and heart; Opsumit, an orally available endothelin receptor antagonist; and Valchlor, a chemotherapeutic agent for the treatment of mycosis fungoides, a common type of cutaneous T-cell lymphoma. The company also provides Veletri, a formulation of epoprostenol for the treatment of PAH; Ventavis, an inhaled formulation of iloprost for the treatment of PAH; and Zavesca, an oral treatment for patients with mild to moderate type 1 Gaucher disease for whom enzyme replacement therapy is unsuitable. Actelion Ltd markets its products in Switzerland, the United States, Japan, China, Russia, and Mexico. The company was founded in 1997 and is headquartered in Allschwil, Switzerland.
© 2005-2019 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service